Summary & Overview

CPT 86021: Leukocyte Antibody Identification, Technical Laboratory Service

CPT code 86021 designates the technical laboratory procedure to analyze patient specimens for the presence of and identify leukocyte antibodies. This immunohematology service is a routine component of transfusion medicine and immunology workflows, informing compatibility assessment, transplant evaluation, and certain diagnostic investigations. Nationally, accurate reporting of this CPT code ensures appropriate classification of lab services performed by hospital and independent clinical laboratories.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for leukocyte antibody testing, typical sites of service, and the technical nature of the procedure. The publication outlines common billing modifiers and payer coverage patterns where available, provides benchmark and reimbursement context when reported, and notes relevant policy or claim adjudication considerations that affect submission and payment for this laboratory technical service.

This summary is written for a national audience and is intended to orient clinicians, billing staff, and policy analysts to the clinical purpose and billing role of CPT code 86021, and to signal the sections that follow for deeper detail on payers, modifiers, and related billing guidance.

AetnaBlue Cross Blue ShieldCignaUnitedHealthcareMedicare86021CPTLaboratoryImmunohematologyLeukocyte AntibodyTechnical ComponentTransfusion MedicineLaboratory BillingPathology

Billing Code Overview

CPT code 86021 describes a laboratory technical service in which a lab analyst performs testing to detect the presence of and identify leukocyte antibodies. This service involves processing patient specimens, running immunohematology assays, and producing the technical component of antibody identification results.

Service type: Laboratory/Pathology — Technical Component

Typical site of service: Clinical laboratory or hospital laboratory

Clinical & Coding Specifications

Clinical Context

A 32-year-old pregnant woman presents for routine prenatal blood testing following a prior pregnancy complicated by hemolytic disease of the newborn. Her prenatal laboratory panel flags a positive antibody screen. A blood specimen is sent to the hospital transfusion medicine laboratory where a medical laboratory scientist performs specialized serologic testing to detect and identify leukocyte (white blood cell) antibodies that may affect transfusion compatibility or cause alloimmune fetal/neonatal complications. The lab workflow includes receipt and accessioning of the specimen, verification of patient identifiers and clinical history, performance of antibody detection/enzyme-linked or flow-based assays, interpretation by a qualified technologist, and reporting of results into the electronic medical record for the ordering clinician and transfusion service.

Typical site of service is an accredited hospital clinical laboratory or independent reference immunohematology/transfusion medicine laboratory. The service type is a technical laboratory procedure performed by trained laboratory personnel to analyze for the presence of and identify leukocyte antibodies; results inform transfusion decisions, organ transplant compatibility assessment, and management of alloimmune conditions in pregnancy.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when billing only the professional (interpretive) component of a test if split billing applies and the performing lab reports only the technical component.
`TC`	Technical component	Use when billing only the technical component of the test performed by the laboratory.
`90`	Reference (outside) laboratory	Use when the specimen is referred to an outside reference laboratory for performance of the test.
`91`	Repeat clinical diagnostic laboratory test	Use when a repeat test is performed on the same day and reporting of subsequent results is required.
`59`	Distinct procedural service	Use when services on the same date are separate and distinct from other laboratory or transfusion procedures.
`52`	Reduced services	Use when a reduced service is provided relative to the full description (e.g., limited panel performed).
`53`	Discontinued procedure	Use if testing was started but discontinued for documented medical reasons.
`22`	Increased procedural services	Use to report unusually complex or time-consuming testing beyond typical scope with appropriate documentation.
`78`	Unplanned return to the operating/procedure room	Not typically used for this lab test but applicable when post-procedure surgical re-entry necessitates repeat testing related to the procedure.
`90`	Reference lab (duplicate entry removed)	Duplicate entries are not permitted; included above.

Taxonomy Code	Specialty	Notes
338M00000X	Pathology & Laboratory Medicine	Transfusion medicine and immunohematology specialists who oversee serologic testing.
207K00000X	Surgery, Transplant	Transplant surgeons coordinating crossmatch and leukocyte antibody testing for donor compatibility.
207L00000X	Obstetrics & Gynecology	OB/GYNs ordering alloimmune testing during pregnancy for maternal antibodies.
207P00000X	Hematology	Hematologists managing transfusion-dependent patients and antibody workups.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`O36.2130`	Maternal care for isoimmunization, unspecified trimester, fetus 0	Maternal alloimmunization can involve leukocyte antibodies that affect the fetus; testing identifies antibodies relevant to management.
`D59.0`	Drug-induced autoimmune hemolytic anemia	Antibody testing can help characterize immune-mediated blood cell destruction and guide transfusion decisions.
`D56.9`	Sickle-cell disease, unspecified	Patients with chronic transfusion needs are screened for leukocyte and platelet antibodies to optimize transfusion compatibility.
`Z51.3`	Encounter for antineoplastic chemotherapy and immunotherapy	Cancer patients receiving multiple transfusions may develop leukocyte antibodies; testing informs safe transfusion practice.
`Z03.89`	Encounter for observation for other suspected diseases and conditions	When unexpected antibody reactions are suspected, leukocyte antibody identification may be ordered during observation.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`86038`	Antibody identification; serum, each panel	Performed when an antibody screen is positive to identify specific red cell or leukocyte antibodies; often follows initial antibody detection.
`86850`	Crossmatch, serologic	Performed to assess compatibility between donor and recipient blood when leukocyte or other antibodies are present; may follow identification testing.
`86830`	Blood typing; ABO	Basic transfusion testing that is part of the overall immunohematology workflow alongside leukocyte antibody identification.
`86900`	Compatibility test; antilymphocyte/antigranulocyte crossmatch	Relevant when specialized compatibility testing involving leukocyte-directed antibodies is required for transplant or transfusion.
`86148`	Antibody screen, platelet or granulocyte	Platelet or granulocyte antibody testing is complementary when leukocyte antibodies affecting transfusion products are suspected.